P309-1212 Screening compound: N-[(4-chlorophenyl)methyl]-3-(4-methylbenzamido)pyrazine-2-carboxamide

P309-1212 Screening compound: N-[(4-chlorophenyl)methyl]-3-(4-methylbenzamido)pyrazine-2-carboxamide
P309-1212 Screening compound: N-[(4-chlorophenyl)methyl]-3-(4-methylbenzamido)pyrazine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P309-1212
N-[(4-chlorophenyl)methyl]-3-(4-methylbenzamido)pyrazine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P309-1212

Molecular Formula

C20H17ClN4O2 (C20 H17 ClN4 O2)

Compound Name

N-[(4-chlorophenyl)methyl]-3-(4-methylbenzamido)pyrazine-2-carboxamide

IUPAC name

N-[(4-chlorophenyl)methyl]-3-(4-methylbenzamido)pyrazine-2-carboxamide

SMILES

Cc(cc1)ccc1C(Nc1nccnc1C(NCc(cc1)ccc1Cl)=O)=O

InChI

InChI=1S/C20H17ClN4O2/c1-13-2-6-15(7-3-13)19(26)25-18-17(22-10-11-23-18)20(27)24-12-14-4-8-16(21)9-5-14/h2-11H,12H2,1H3,(H,24,27)(H,23,25,26)

InChI Key

AKOHIZKXVVOFCT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27571429

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

380.83

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.258

Distribution Coefficient, logD

2.457

Water Solubility, LogSw

-3.70

Polar Surface Area

67.249

Acid Dissociation Constant (pKa)

6.67

Base Dissociation Constant (pKb)

-2.02

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.00

P309-1212 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

C-Met Library (15277 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Proteases
  • Others
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with P309-1212 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P309-1212?
Check Price and Availability of P309-1212, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P309-1212 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P309-1212
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P309-1212
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P309-1212 available by request